Brooks Labs share price is Up ▲ 8.91% on 06-Aug-2024

Brooks Labs share price is Up ▲ 8.91% on 06-Aug-2024. | 472.25k shares traded.
Its CMP is Rs 109.38 and MCap is approx : 270 Crs.
The stock is up ▲ 20.2% in 7 days,
up ▲ 25.8% in 1 month
and up ▲ 43.7% in 2 months.
Please click image for Latest Daily data.
Brooks Labs results Mar 2024 (Standalone_YoY) revenue elevated to 18 crores up 38% in Mar 2024 quarter, compared with 13 crores in Mar 2023. Its Net loss is 0 crores up 100% in Mar 2024 quarter, compared with -1 crores in last year same quarter. Please click Image for Daily Data and results of the stock.
* Data updated everyday at 7pm. Only Data. Not Buy or Sell advice.

Click Image for Data | Scroll down for Comments

About Brooks Labs :

Founded: 2002
Headquarters: India
Number of employees: 296 (2023)
Subsidiary: Brooks Steriscience Limited

Brooks Laboratories Limited is an Indian pharmaceutical company that manufactures and sells drugs and pharmaceuticals internationally. The company was founded in 2002 and is based in Mumbai, India, with manufacturing sites in Baddi, Himachal Pradesh. Brooks Laboratories is known for its research, manufacturing, and value creation, and offers a variety of pharmaceutical dosage forms, including tablets, injections, dry syrup, eye/ear drops, and carbapenem drugs.

Brooks Laboratories has been committed to improving global healthcare for over 20 years. The company has established itself as a reputable contract manufacturing company for the latest molecules in injectables and clavulanic acid range in tablets and dry syrups.
—————————————————-
* About company information is from various sources on the internet ( March 2024 ).
Please verify the official website of company for the latest updated information.
—————————————————-

Please visit